First valsartan/amlodipine fixed dose combination tablet now available

  • Product News

Abstract

Novartis Pharmaceuticals is proud to announce the launch of EXFORGE®, the first valsartan/amlodipine fixed dose combination tablet available in South Africa.1 This is used for the treatment of mild to moderate essential hypertension in patients whose blood pressure is normalised with the individual components in the same doses as the proposed fixed dose combination of EXFORGE®.
Section
News